Crossing the barrier: nanomedicine as a frontier therapy for neuropathic Gaucher disease type 3
Related Experiment Video
Updated: Jul 20, 2026

06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
8.1K
Minahil Saif1, Aeyza Nasir1, Sabeen Shafique1
1Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Annals of Medicine and Surgery (2012)
|January 7, 2026
Abstract
No abstract available in PubMed .

